A 'high-quality' lead compound has the following desirable qualities

Question

BlackTom AI · Accepted Answer

Smaller and less lipophilic.

1) Relevant knowledge points and concepts
- Lead compounds in medicinal chemistry should be “lead-like”: moderate molecular weight, moderate polarity, and balanced lipophilicity to allow good solubility, permeability and amenability to optimization.
- Lipophilicity (often expressed as LogP) impacts solubility, metabolic clearance, plasma protein binding and off-target toxicity.
- Ligand efficiency metrics (e.g., Lipophilic Efficiency, LipE = pIC50 − LogP) favor potency gained without excessive lipophilicity.
- Excessive rotatability (high flexibility) can reduce binding specificity and oral bioavailability; very large, very lipophilic molecules often have poor ADME properties.

2) Step‑by‑step reasoning
- Start from desired downstream properties: a high‑quality lead should be easy to optimize into a drug candidate with good ADME/Tox. That requires a compact scaffold with room for adding functionality to increase potency without blowing up size or lipophilicity.
- Smaller size (lower molecular weight) increases the chance of good solubility and cell permeability and leaves synthetic space for optimization.
- Lower lipophilicity reduces nonspecific binding, reduces metabolic clearance issues and improves aqueous solubility; this supports higher ligand efficiency and a better therapeutic index.
- Therefore a lead that is smaller and less lipophilic provides a better starting point.

3) Intermediate “calculations” / examples
- Example LipE comparison: Compound X pIC50 = 7 (100 nM) with LogP = 2 → LipE = 5 (good). Compound Y pIC50 = 8 (10 nM) with LogP = 5 → LipE = 3 (worse despite higher potency). This shows high potency alone is not sufficient if lipophilicity is excessive.

4) Why the correct answer is correct
- Option b (“smaller and less lipophilic”) directly embodies lead-like principles: better solubility, easier ADME optimization, higher ligand efficiency and lower risk of off-target effects.

5) Why other options are incorrect
- a (very rotatable): High flexibility usually lowers oral bioavailability and binding specificity—undesirable.
- c (large and very lipophilic): Causes poor solubility, high clearance, high protein binding and toxicity risk.
- d (low potency): Low potency is obviously undesirable; leads should have measurable potency to optimize from.

6) Conclusion
- Based on lead-like design principles and ligand efficiency considerations, the correct choice is b. This matches the provided answer.

A 'high-quality' lead compound has the following desirable qualities单项选择题

类似问题

Library design in PDD;

Which statement best describes a lead-like library?

What are 5 of the issues that may need to be addressed in the decision-making process when choosing a lead compound?在选择先导化合物时，决策过程中可能需要解决的五个问题有哪些？

A 'high-quality' lead compound has the following desirable qualities

Lead compounds can only come from natural sources

Lipinski's rule of 5 (Ro5) is applicable to the development of: Select all correct answers.

Lead compounds for new drugs can only be synthesized.

Which stages commonly include evaluation of compound safety? (Select all that apply)

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单